• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Relationship between physical function and quality of life based on treatment timing in patients with advanced lung cancer.基于治疗时机的晚期肺癌患者身体功能与生活质量的关系
J Phys Ther Sci. 2025 Jan;37(1):12-20. doi: 10.1589/jpts.37.12. Epub 2025 Jan 1.
2
Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial.在先前接受铂类化疗的非小细胞肺癌患者中,二线多西他赛与最佳支持治疗的生活质量评估:一项前瞻性、随机III期试验的结果
Lung Cancer. 2004 Feb;43(2):183-94. doi: 10.1016/j.lungcan.2003.09.001.
3
Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).阿法替尼治疗厄洛替尼或吉非替尼治疗后进展的晚期非小细胞肺癌患者的症状和生活质量获益:一项随机 IIb/III 期试验(LUX-Lung 1)的结果。
J Thorac Oncol. 2013 Feb;8(2):229-37. doi: 10.1097/JTO.0b013e3182773fce.
4
Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.欧洲癌症研究与治疗组织生活质量问卷(QLQ-C30)在乳腺癌、卵巢癌和肺癌患者中的心理测量特性及反应性
Qual Life Res. 1994 Oct;3(5):353-64. doi: 10.1007/BF00451727.
5
Health-related quality of life and symptoms in patients with previously untreated, locally advanced or metastatic non-squamous non-small cell lung cancer treated with sintilimab or placebo plus pemetrexed and platinum (ORIENT-11): A randomized, double-blind, phase 3 trial.信迪利单抗或安慰剂联合培美曲塞及铂类治疗既往未治疗的局部晚期或转移性非鳞状非小细胞肺癌患者的健康相关生活质量和症状(ORIENT-11):一项随机、双盲、3期试验
Lung Cancer. 2025 Feb;200:108108. doi: 10.1016/j.lungcan.2025.108108. Epub 2025 Jan 27.
6
Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.评估接受根治性放疗或术后放疗的非小细胞肺癌长期存活者的生活质量和肺功能。
Am J Clin Oncol. 2009 Feb;32(1):65-72. doi: 10.1097/COC.0b013e31817e6ec2.
7
Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor-naive ALK + non-small cell lung cancer (ALTA-1L).在 III 期随机临床试验中,brigatinib 对比crizotinib 治疗初治晚期 ALK 阳性非小细胞肺癌(ALTA-1L)患者的健康相关生活质量。
Lung Cancer. 2021 May;155:68-77. doi: 10.1016/j.lungcan.2021.03.005. Epub 2021 Mar 9.
8
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.厄洛替尼和吉非替尼用于治疗先前化疗后进展的非小细胞肺癌(英国国家卫生与临床优化研究所技术评估162和175回顾):一项系统评价与经济学评估
Health Technol Assess. 2015 Jun;19(47):1-134. doi: 10.3310/hta19470.
9
What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?--Results from the lung cancer economics and outcomes research (LUCEOR) study.在治疗晚期非小细胞肺癌患者时,什么构成了最佳支持治疗?——来自肺癌经济学和结果研究(LUCEOR)的结果。
Lung Cancer. 2013 Oct;82(1):128-35. doi: 10.1016/j.lungcan.2013.06.023. Epub 2013 Jul 31.
10
Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study Group.接受支持治疗加卡铂和依托泊苷化疗或仅接受支持治疗的晚期非小细胞肺癌患者的生活质量和生存率。一项多中心随机III期试验。联合肺癌研究组。
Eur J Cancer. 1998 Jun;34(7):1036-44. doi: 10.1016/s0959-8049(97)10122-8.

本文引用的文献

1
Association of fatigue, inflammation, and physical activity on gait speed: the Long Life Family Study.疲劳、炎症与身体活动对步态速度的影响:长寿家族研究。
Aging Clin Exp Res. 2022 Feb;34(2):367-374. doi: 10.1007/s40520-021-01923-x. Epub 2021 Jul 1.
2
Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis.患者报告结局作为肿瘤学中生存的独立预后因素:系统评价和荟萃分析。
Value Health. 2021 Feb;24(2):250-267. doi: 10.1016/j.jval.2020.10.017. Epub 2021 Jan 6.
3
Exercise training for advanced lung cancer.晚期肺癌的运动训练
Cochrane Database Syst Rev. 2019 Feb 11;2(2):CD012685. doi: 10.1002/14651858.CD012685.pub2.
4
Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.虚弱评估可预测晚期肺癌患者第一周期化疗期间的毒性,而与实际年龄无关。
J Geriatr Oncol. 2019 Jan;10(1):48-54. doi: 10.1016/j.jgo.2018.06.007. Epub 2018 Jul 10.
5
Histologic subtypes are not associated with the presence of sarcopenia in lung cancer.组织学亚型与肺癌中的肌肉减少症无关。
PLoS One. 2018 Mar 28;13(3):e0194626. doi: 10.1371/journal.pone.0194626. eCollection 2018.
6
Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer.化疗期间骨骼肌耗竭对老年晚期非小细胞肺癌日本患者的身体功能有很大影响。
BMC Cancer. 2017 Aug 25;17(1):571. doi: 10.1186/s12885-017-3562-4.
7
Walking energetics, fatigability, and fatigue in older adults: the study of energy and aging pilot.老年人的行走能量代谢、易疲劳性和疲劳:能量与衰老试点研究
J Gerontol A Biol Sci Med Sci. 2015 Apr;70(4):487-94. doi: 10.1093/gerona/glu146. Epub 2014 Sep 4.
8
Changes in and Associations Among Functional Status and Perceived Quality of Life of Patients With Metastatic/Locally Advanced Cancer Receiving Rehabilitation for General Disability.接受一般性残疾康复治疗的转移性/局部晚期癌症患者的功能状态变化及其与生活质量感知之间的关联
Am J Hosp Palliat Care. 2015 Nov;32(7):695-702. doi: 10.1177/1049909114537871. Epub 2014 Jun 5.
9
Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.亚洲肌少症共识报告:亚洲肌少症工作组报告
J Am Med Dir Assoc. 2014 Feb;15(2):95-101. doi: 10.1016/j.jamda.2013.11.025.
10
Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer.雄激素剥夺疗法治疗前列腺癌男性患者的身体和一般健康的抵抗和有氧运动干预效果的介导物。
Cancer. 2014 Jan 15;120(2):294-301. doi: 10.1002/cncr.28396. Epub 2013 Oct 7.

基于治疗时机的晚期肺癌患者身体功能与生活质量的关系

Relationship between physical function and quality of life based on treatment timing in patients with advanced lung cancer.

作者信息

Muraoka Norihiko, Ro Takanori, Ota Tetsuo

机构信息

Rehabilitation Unit, Asahikawa Medical University Hospital: 2-1-1-1 Midorigaokahigashi, Asahikawa-shi, Hokkaido 078-8510, Japan.

出版信息

J Phys Ther Sci. 2025 Jan;37(1):12-20. doi: 10.1589/jpts.37.12. Epub 2025 Jan 1.

DOI:10.1589/jpts.37.12
PMID:39764298
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11700573/
Abstract

[Purpose] Rehabilitation can improve physical function and quality of life in patients with advanced cancer. However, relevant studies on advanced lung cancers are limited. Differences in physical function and symptoms based on the treatment phase should be considered. This study investigated the relationship between physical function and quality of life during the treatment phase in patients with advanced lung cancer. [Participants and Methods] Patients with stage IV non-small-cell lung cancer and postoperative recurrence who were hospitalized between May 2018 and October 2021 were selected. Data, including age, histological type of lung cancer, treatment details, functional independence measures, and European Organization for Research and Treatment of Cancer QLQ-C30, were collected from medical records. Patients were categorized into groups based on the treatment phase: the initial, subsequent, and best supportive care (BSC) groups comprised patients admitted for initial treatment, receiving second or subsequent treatments, and receiving best supportive care, respectively. The relationship between physical function and quality of life during each treatment phase was examined. [Results] Physical function in the subsequent group was associated with physical functioning, role functioning, cognitive functioning, social functioning, and fatigue. Meanwhile, the BSC group had fewer associated items than the other groups. [Conclusion] Rehabilitation during the ongoing treatment phase improves physical function and quality of life.

摘要

[目的] 康复治疗可改善晚期癌症患者的身体功能和生活质量。然而,关于晚期肺癌的相关研究有限。应考虑基于治疗阶段的身体功能和症状差异。本研究调查了晚期肺癌患者治疗阶段身体功能与生活质量之间的关系。[参与者与方法] 选取2018年5月至2021年10月期间住院的IV期非小细胞肺癌及术后复发患者。从病历中收集包括年龄、肺癌组织学类型、治疗细节、功能独立性测量以及欧洲癌症研究与治疗组织QLQ-C30等数据。根据治疗阶段将患者分为几组:初始治疗组、后续治疗组和最佳支持治疗(BSC)组,分别包括接受初始治疗、接受第二次或后续治疗以及接受最佳支持治疗的患者。研究了每个治疗阶段身体功能与生活质量之间的关系。[结果] 后续治疗组的身体功能与身体机能、角色功能、认知功能、社会功能和疲劳相关。同时,BSC组的相关项目比其他组少。[结论] 在持续治疗阶段进行康复治疗可改善身体功能和生活质量。